BioMarin Pharmaceutical Inc. buy Piper Sandler
Start price
27.08.24
/
50%
€80.88
Target price
27.08.25
€95.81
Performance (%)
-38.16%
End price
28.08.25
€50.02
Summary
This prediction ended on 28.08.25 with a price of €50.02. Massive losses of -38.16% were the result for the BUY prediction by Piper_Sandler. Piper_Sandler has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | 2.356% | 2.356% | 5.452% |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% |
Comments by Piper_Sandler for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $107.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Current prediction by Piper_Sandler for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€49.09
06.02.26
06.02.26
€71.25
06.02.27
06.02.27
7.97%
27.07.26
27.07.26
Stopped prediction by Piper_Sandler for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€68.34
20.02.25
20.02.25
€120.57
20.02.26
20.02.26
-21.69%
21.02.26
21.02.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€75.46
05.09.24
05.09.24
€109.96
05.09.25
05.09.25
-34.85%
06.09.25
06.09.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€84.34
23.02.24
23.02.24
€98.83
23.02.25
23.02.25
-22.62%
24.02.25
24.02.25